COMMENTARY
For over 10 years the World Health Organization (WHO) and the joint United Nations Program on HIV and AIDS (UNAIDS) have recommended that condoms be made available to prisoners. There has been tremendous reluctance to implement these recommendations in most jurisdictions. They are only available in a handful of correctional systems in the United States. One of the major concerns is that distribution of condoms could encourage prisoners to have sex and might result in increased sexual assault or that condoms would be used for other illicit purposes such as hiding drugs. This study provides objective data to refute those concerns, and given that there is ongoing high-risk sexual behavior among some individuals who are incarcerated, clearly free access to condoms for prisoners is warranted. The authors surveyed imprisonment rates, prisoner HIV prevalence and proportion of prisoners who are injection drug users in 152 low-income and middle-income countries. Imprisonment ranged from 23 per 100,000 population in Burkina Faso to 532 per 100,000 in Belarus and Russia. HIV prevalence was greater than 10% in prisons in 20 out of 75 countries and greater than 10% among 
SUMMARY
The authors interviewed 209 injection drug users in three Russian cities about their experiences related to arrest, incarceration, and drug use. They found that 77% had been arrested related to their drug use and 35% had a history of detention. Drugs were perceived to be generally available in penitentiary institutions; however, sterile injection equipment was scarce and, as a consequence, routinely shared, including within large groups. Risk reduction was severely constrained by a combination of lack of injecting equipment availability and punishment for possession. The authors conclude there is an urgent need for HIV prevention and intervention in the Russian penitentiary system.
COMMENTARY
Several studies to date on incarcerated populations in the US have concluded that HIV transmission in the incarcerated setting does occur, but that it is generally at a lower rate than similar populations in the community. That may be caused by an overall decrease in risky behaviors during incarceration. However, as documented in both these articles, very-high-risk activities and high prevalences of HIV infection in the incarcerated populations do occur in many locations. Worldwide attention should be focused on implementing and evaluating HIV prevention strategies in the incarcerated setting. 
SUMMARY
This is a retrospective cohort study of 30,237 individuals who were released from Washington State prisons between 1999 and 2003. The authors found the mortality rate was 777 deaths per 100,000 person-years. The adjusted risk of death among former inmates was 3.5 times higher than other state residents. During the first 2 weeks after release, the risk of death among former inmates was 12.7 times that among other state residents and even higher in the first week after release. The leading causes of death among former inmates were drug overdose, cardiovascular disease, homicide, and suicide. The authors conclude that former prison inmates were at high risk for death after release, particularly in the few weeks after release from incarceration and that interventions are necessary to reduce this risk.
